Central serous chorioretinopathy: An update on pathogenesis and treatment

Eye

Volumn 24, Issue 12, 2010, Pages 1743-1756

  Gemenetzi, M ^a   De Salvo, G ^a   Lotery, A J ^a,b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

central serous retinopathy; review; treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE; KETOCONAZOLE; MIFEPRISTONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; TOLAZOLINE; VERTEPORFIN;

ARGON LASER; ARTICLE; CENTRAL SEROUS RETINOPATHY; CUSHING SYNDROME; DIODE LASER; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTORECEPTOR MEMBRANE; PREGNANCY; PSYCHOTHERAPY; RETINA DETACHMENT; RETINA FOVEA; RETINA MACULA EDEMA; STRESS; SYMPTOM; THROMBOCYTE AGGREGATION; TRANSPUPILLARY THERMOTHERAPY; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 78650240629     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.130     Document Type: Article

References (153)

1. Von Graefe A. Kurzere Abhandlungen. Notizen und casaistische Mitheilungen vermischten Inhalts: VI. Ueber zentrale recidivirende Retinitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1866; 12: 211-215.
2. Yannuzzi LA. Type-A behaviour and central serous chorioretinopathy. Retina 1987; 7: 111-130.
3. Klein B. Macular diseases: Clinical manifestations. Central serous retinopathy and chorioretinopathy. Trans Am Acad Ophthalmol Otorynolaryngol 1965; 69: 614-620.
4. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967; 63: 587-615.
5. Yannuzzi LA, Shakin J, Fisher Y, Altomonte MA. Peripheral retinal detachment and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984; 91: 1554-1572.
6. Horniker E. Su di unaforma di retinite centrale di origine vasoneurotica. Ann Ottalmol 1927; 55: 578-600, 830-840, 865-883.
7. Maumenee AE. Symposium on macular diseases: Clinical manifestations. Trans Am Acad Ophthalmol Otolaryngol 1965; 69: 605-613.
8. Gass JDM. Pathogenesis of disciform detachment of the Neuroepithelium: I. General concepts and classifications. Am J Ophthalmol 1967; 63: 573-585.
9. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: III. Senile disciform macular degeneration. Am J Ophthalmol 1967; 63: 617-644.
10. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: IV. Fluorescein angiographic study of senile disciform macular degeneration. Am J Ophthalmol 1967; 63: 645-659.
11. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: V. Disciform macular detachment secondary to focal choroiditis. Am J Ophthalmol 1967; 63: 661-687.
12. Ryan SJ. Central serous chorioretinopathy. Retina 3rd edn. 2001; 2: 1153-1181.
13. Fuchs E. Ein Fall von zentraler residivierender syphilitischer Netzhaut Enzundung. Zentralbl Prakt Augenheilkd 1916; 40: 105-108.
14. Guist G. Ueber preretinales Oedema. Z Augenheilkd 1925; 54: 37-49.
15. Kitahara S. Ueber klinische Beobachtungen bei der in Japan haufig vorkommenden Chorioretinitis sentralis serosa. Klin Monatsbl Augenheilkd 1936; 97: 345-362.
16. Reiger H. Zur Atiologic der Retinitis exudative externa centralis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1960; 00: 000-000.
17. Djakri SE, Dilinas N. L'importance de la lambliase comme facteur etiologique dans la chorioretinite centrale sereuse. Ophthalmologica 1963; 147: 264-272.
18. Si-Boen-Lian. The etiologic agent of central serous central chorioretinitis. Ophthalmologica 1964; 148: 263-267.
19. Ko HU. An experimental study of the nature of Masuda's chorioretinitis: III. A study of the relationship existing between chorioretinitis centralis photodynamica and the function of the kidney. Acta Soc Ophthalmol Jpn 1934; 38: 1060-1073.
20. Redman SI. A review of solar retinitis as it may pertain to macular lesions seen in persons of the armed forces. Am J Ophthalmol 1945; 28: 1155-1165.
21. Delman M, Leubuscher K. Transient macular edema due to griseofulvin. Am J Ophthalmol 1963; 56: 658.
22. Haynes SB, Levine S, Scotch NA, Feinleib M, Kannel WB. The relationship of psychological factors to coronary heart disease in the Framingham Study: I. Methods and risk factors. Am J Epidemiol 1978; 107: 362-383. (Pubitemid 9003484)
23. Burton T. Central serous retinopathy. In: FC Blodi (ed) Current Concepts in Ophthalmology. St Louis: CV Mosby, 1972, pp 1-28.
24. Bettman JW. Allergic retinosis. Am J Ophthalmol 1945; 28: 1323-1328.
25. Lothman L. Clinical Manifestations of Allergy in Ophthalmology Year Book of EENT. Year Book Medical Publishers: Chicago, 1941, pp 38-41.
26. Berens C, Sayad WY, Girard LJ. Symposium on ocular allergy. The uveal tract and retina: Consideration of certain experimental and clinical concepts. Trans Am Acad Ophthalmol Otolaryngol 1952; 56: 220-241.
27. Hassan L, Carvalho C, Yannuzzi LA, Iida T, Negrão S. Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or 'ecstasy'. Retina 2001; 21: 559-561.
28. Nagayoshi K. Experimental study of chorioretinopathy by intravenous injection of adrenaline. Nippon Ganka Gakkai Zasshi 1971; 75: 1720-1727.
29. Miki T, Sunada E, Higaki T. Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine). Nippon Ganka Gakkai Zasshi 1972; 76: 1037-1045.
30. Yoshioka H, Sugita T, Nagayoshi K. Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report. Nippon Ganka Kiyo 1970; 21: 648-652.
31. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: Fluorescein angiographic findings. Ophthalmologica 1982; 185: 168-178. (Pubitemid 12031626)
32. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Allen H, Orlock D. Digital indocyanine-green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057-1062. (Pubitemid 24272611)
33. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 11: 26-34. (Pubitemid 26026078)
34. Giovannini A, Scassellati-Sforzolini B, D'Altobrando et al. Choroidal findings in the course of idiopathic serous pigment epithelial detachment detected by indocyanine green videoangiography. Retina 1997; 17: 286-293.
35. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalomol 1984; 68: 329-331.
36. Polak BCP, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalomol 1995; 79: 922-925.
37. Heimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997; 104: 1653-1660.
38. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalomol 1997; 81: 962-964.
39. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser- Kupfer MI. Central serous chorioretinopathy in edogenous hypercortisolism. Arch Ophthalmol 1993; 111: 1229-1233.
40. Harrington DO. Psychosomatic interrelationship in ophthalmology. Am J Ophthalmol 1948; 31: 1241-1251.
41. Yoshioka H. The etiology of central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi 1991; 95: 1181-1195.
42. Avci R, Deutman AF. Die Behandlung der zentralen serösen Choroidopathie mit dem Betarezeptorenblocker Metoprolol (Vorläufige Ergebnisse). Klin Monatsbl Augenheilkd 2005; 202: 199-205.
43. Gonzalez C. Décollements séreux retiniens. J Fr Ophthalmol 1992; 15: 529536.
44. Robertson DM, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457-466.
45. Burumcek E, Mudun A, Karakocoglu S, Arslan MO. Laser photocoagulation for persistent central serous retinopathy: Results of lonf term follow-up. Ophthalmology 1997; 104: 616-622.
46. Yap EY, Robertson DM. The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996; 114: 689-692.
47. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002; 133: 787-793.
48. Shukla D, Kolluru C, Vignesh TP et al. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy. Eye 2006; 22: 100-106.
49. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003; 23: 235-237.
50. Canakis C, Livir-Rallatos C, Panayiotis Z, Livir-Rallatos G, Persidis E, Conway MD et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 2003; 136: 750-752.
51. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23: 752-763.
52. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ. Indocyanine green angiography- guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: A pilot study. Retina 2003; 23: 288-298.
53. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green angiography guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453-1458.
54. Torres-Soriano ME, García-Aguirre G, Kon-Jara V, Ustariz- Gonzáles O, Abraham-Marín M, Ober MD et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports). Graefes Arch Clin Exp Ophthalmol 2008; 246: 1235-1239.
55. Seong HK, Bae JH, Kim ES, Han JR, Nam WH, Kim HK. Intravitreal bevacizumab to treat acute central serous chorioretinopathy: Short-term effect. Ophthalmologica 2009; 223: 343-347.
56. Huang WC, Chen WL, Tsai YY, Chiang CC, Lin JM. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eye 2009; 23(2): 488-489.
57. Schaal KB, Hoeh AE, Scheurle A, Schuett F, Dithmar S. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 2009; 19(4): 613-617.
58. Golshahi A, Klingmü ller D, Holz FG, Eter N. Ketoconazole in the treatment of idiopathic central serous chorioretinopathy. Meeting abstract 9/22/2004; Jahrestagung der DOG Deutsche Ophthalmologische Gesellschaft eV 2. Berlin. 59 Meyerle CB, Freund KB, Bhatnagar P, Shah V, Yannuzzi LA et al. Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina 2007; 27: 943-946.
59. Gass JD. Specific diseases causing disciform macular detachment. Stereoscopic Atlas of Macular Diseases 1997; 1: 52-70.
60. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986; 9: 37-41.
61. Tittl M, Maar N, Polska E, Weigert G, Stur M, Schmetterer L. Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy. IOVS; 2005; 46: 4717-4721.
62. Tittl M, Polska E, Kircher K, Kruger A, Maar N, Stur M et al. Topical fundus pulsation measurements in patients with active central serous chorioretinopathy. Arch Ophthalmol 2003; 121: 975-978.
63. Spitznas M. Pathogenesis of central serous retinopathy: A new working hypothesis. Graefe's Arch Clin Exp Ophthalmol 1986; 224: 321-324.
64. Negi A, Marmor MF. Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 1984; 102: 445-449.
65. Marmor MF. New hypothesis on the pathogenesis and treatment of serous retinal detachment. Graefe's Arch Clin Exp Ophthalmol 1988; 226: 548-552.
66. Lewis ML. Idiopathic serous detachment of the retinal pigment epithelium. Arch Ophthalmol 1978; 96: 620-624.
67. Laatikainen L, Hoffren M. Long-term follow-up study of nonsenile detachment of the retinal pigment epithelium. Eur J Ophthalmol 1991; 1: 79-84.
68. Mudvari SS, Goff MJ, Fu AD, McDonald HR, Johnson RN, Ai E, Jumper JM. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina 2007; 27: 1168-1173.
69. Loo RH, Scott IU, Flynn Jr HW, Gass JD, Murray TG, Lewis ML et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22: 19-24.
70. Perkins SL, Kim JE, Pollack JS, Merrill PT. Clinical characteristics of central serous chorioretinopathy in women. Ophthalmology 2002; 109: 262-266.
71. Sawa T, Gomi F, Tano Y. Three-dimensional optical coherence tomographic findings of idiopathic multiple serous retinal pigment epithelial detachment. Arch Ophthalmol 2005; 123: 122-123.
72. Iida T, Hagimura N, Sato T, Kishi S. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000; 129: 16-20.
73. Montero JA, Ruiz-Moreno JM. Optical coherence tomography characterization of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2005; 89: 562-564.
74. Mitarai K, Gomi F, Tano Y. Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy. Graefe's Arch Clin Exp Ophthalmol 2006; 244: 1415-1420.
75. Hirami Y, Tsujikawa A, Sasahara M, Gotoh N, Tamura H, Otani A et al. Alterations of retinal pigment epithelium in central serous chorioretinopathy. Clin Experiment Ophthalmol 2007; 35: 225-230.
76. Gupta P, Gupta V, Dogra MR, Singh R, Gupta A et al. Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol 2010; 30(2): 175-181.
77. Marmor MF, Tan F. Central serous chorioretinopathy: Bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol 1999; 117: 184-188.
78. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL. et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996; 16: 203-213.
79. Yoshioka H, Katsume Y. Experimental central serous chorioretinopathy: III. Ultrastructural findings. Jpn J Ophthalmnol 1982; 26: 397-409. (Pubitemid 13180728)
80. Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticoseroids and catecholamines in the pathogenesis of central serous chorioretinopathy: A rationale for new treatment strategies. Ophthalmology 2002; 109: 1765-1766.
81. Carvalho-Recchia C, Yannuzzi L, Negrao S, Spaide RF, Freund KB, Rodriguez-Coleman H et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002; 109: 1834-1837.
82. Godel V, Blumenthal M, Regenbogen L. Retrobulbar neuritis and central serous chorioretinopathy. J Pediatr Ophthalmol 1977; 14: 296-298.
83. Chaine G, Haouat M, Menard-Molcard C. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophthalmol 2001; 24: 139-146.
84. Bouzas EA, Moret P, Pournaras CJ. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids. Graefes Arch Clin Exp Ophthalmol 1999; 237: 166-168.
85. Gass JD, Slamovits TL, Fuller DG, Gieser RG, Lean JS. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992; 110: 1717-1722.
86. Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 1985; 60: 37-44.
87. Matsunaga H, Nishimura T, Uyama N. Recent cases of multifocal posterior pigment epitheliopathy. Rinsho Ganka 1992; 46: 729-733.
88. Eckstein MB, Spalton DJ, Holder G. Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol 1993; 77: 607-609.
89. Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-68.
90. Bouzas E, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431-448.
91. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
92. Kvetnansky R, Pacak K, Fukuhara K, Viskupic E, Hiremagalur B, Nankova B et al. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary- adrenocortical system. Ann NY Acad Sci 1995; 771: 131-158.
93. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003; 110: 698-703.
94. Hadcock JR, Malbon CC. Regulation of 13-adrenergic receptors by 'permissive' hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 1988; 85: 8415-8419.
95. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the a13B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88: 385-389.
96. Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 2001; 65: 367-390.
97. Weenink AC, Borsje RA, Oosterhuis JA. Familial chronic central serous chorioretinopathy. Ophthalmologica 2001; 215: 183-187.
98. Fawzi AA, Holland GN, Kreiger AE, Heckenlively JR, Arroyo JG, Cunningham Jr ET. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 2006; 113: 805-813.
99. Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003; 23: 1-7.
100. Cardillo Piccolino F, De La Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. AmJ Ophthalmol 2005; 139: 87-99.
101. Cardillo Piccolino F, De La Longrais RR, Manea M, Cicinelli S. Posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina 2008; 28: 1008-1012.
102. Cardillo Piccolino F, De La Longrais RR, Manea M, Cicinelli S, Ravera G. Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina 2008; 28: 1146-1150.
103. Erickson PA, Fisher SK, Anderson DH, Stern WH, Borgula GA. Retinal detachment in the cat: The outer nuclear and outer plexiform layers. Invest Ophthalmol Vis Sci 1983; 24: 927-942.
104. Anderson DH, Guerin CJ, Erickson PA, Stern WH, Fisher SK. Morphological recovery in the reattached retina. Invest Ophthalmol Vis Sci 1986; 27: 168-183.
105. Chuang EL, Sharp DM, Fitzke FW, Kemp CM, Holden AL, Bird AC. Retinal dysfunction in central serous retinopathy. Eye 1987; 1: 120-125.
106. Mori T, Pepperberg DR, Marmor MF. Dark adaptation in locally detached retina. Invest Ophthalmol Vis Sci 1990; 31: 1259-1263.
107. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126-145.
108. Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin A in conedominant retinas: A novel pathway for visual-pigment regeneration in daylight. Neuron 2005; 36: 69-80.
109. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 1974; 91: 247-250.
110. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 2001; 79: 417-421.
111. Wong R, Chopdar A, Brown M. Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy. Eye 2004; 18: 262-268.
112. Koskela P, Laatikainen L, von Dickhoff K. Contrast sensitivity after resolution of central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 1994; 232: 473-476.
113. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996; 103: 2070-2080.
114. Sahu DK, Namperumalsamy P, Hilton GF, de Sousa NF. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2000; 84: 485-492.
115. Gass JDM. Bullous retinal detachmentFan unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 1973; 75: 810-821.
116. Benson WE, Shields JA, Annesley Jr WH, Tasman W. Idiopathic central serous chorioretinopathy with bullous retinal detachment. Ann Ophthalmol 1980; 12: 920-924.
117. Schatz H, McDonald HR, Johnson RM, Chan CK, Irvine AR, Berger AR et al. Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology 1995; 102: 1077-1088.
118. McLean JM, Gordon DM, Koteen H. Clinical experience with ACTH and cortizone in ocular diseases. Trans Am Acad Ophthalmol Otolaryngol 1951; 55: 565-575.
119. Purnell JE, Leopold IH. Cortisone in ocular diseases: Further studies. AmJ Ophthalmol 1952; 35: 663-670.
120. Hobbs HE. Macular degeneration treated with cortisone. Proc R Soc Med 1953; 46: 213-218.
121. Pecora JL. Ibuprofen in the treatment of central serous chorioretinopathy. Am J Ophthalmol 1978; 10: 1481-1483.
122. Bialasiewicz A. Uber therapeutische Erfolge bei Retinitis centralis serosa mit Priscoline- injektionen. Klin Monatsbl Augenheilkd 1957; 131: 536-537.
123. Burton T. Central serous retinopathy. In: FC Blodi (ed). Current Concepts in Ophthalmology. CV Mosby: St Louis, 1972, pp 1-28.
124. Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979; 63: 674-677.
125. Watzke RC, Burton TC, Leaverton PE. Ruby laser photocoagulation therapy of central serous retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 205-211.
126. Robertson D, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous retinopathy. Am J Ophthalmol 1983; 95: 457-466.
127. Dellaporta A. Central serous retinopathy. Trans Am Ophthalmol Soc UK 1976; 74: 144-151.
128. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalomol 1984; 68: 815-820.
129. Wang M, Sander B, la Cour M, Larsen M. Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 2005; 83: 691-696.
130. Robertson DM. Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 1986; 93: 972-974.
131. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalomol 1988; 72: 829-834.
132. Sharma T, Shah N, Rao M, Gopal L, Shanmugam MP, Gopalakrishnan M et al. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 2004; 111: 1708-1714.
133. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to seven weeks after treatment. Invest Ophthalmol Vis Sci 1999; 40: 2322-2331.
134. Tarantola RM, Law JC, Recchia FM, Sternberg Jr P, Agarwal A. Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. LasersSurg Med 2008; 40: 671-675.
135. Treatment of age related macular degeneration with Photodynamic Therapy (TAP) Study group. Photodynamic therapy of subfoveal choroidal neovascularization in age related macular degeneration with verteporfin. Arch Ophthalmol 1999; 117: 1329-1345.
136. Lee PY, Kim KS, Lee WK. Severe choroidal ischaemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol 2009; 53: 52-56.
137. Lai TY, Chan WM, Lam DS. Transient reduction in retinal function by multifocal electroretinogram following photodynamic therapy. Am J Ophthalmol 2004; 137: 826-833.
138. Tzekov R, Lin T, Zhang KM, Jackson B, Oyejide A, Orilla W et al. Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci 2006; 47: 377-385.
139. Lai TYY, Chan W-M, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: A short-term pilot study. Br J Ophthalmol 2006; 90: 869-874.
140. Chan WM, Lai TYY, Lai RYK, Liu DT, Lam DS. Half dose verteporfin photodynamic therapy for acute central serous chorioretinopathy. Ophthalmology 2008; 115: 1756-1765.
141. Chan WM, Lai TYY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy. Retina 2008; 28: 85-93.
142. Zhao MW, Zhou P, Xiao HX, Lv YS, Li CA, Liu GD et al. Photodynamic therapy for acute central serous chorioretinopathy: The safe effective lowest dose of verteporfin. Retina 2009; 29: 1155-1161.
143. Reibaldi M, Boscia F, Avitabile T, Russo A, Cannemi V, Uva MG et al. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy. Eur J Ophthalmol 2009; 19: 154-158.
144. Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: A nonrandomized clinical trial. Am J Ophthalmol 2010; 149: 307-315.
145. Inoue R, Sawa M, Tsuyikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010; 149: 441-446.
146. Moon JW, Yu HG, Kim TW, Kim HC, Chung H. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247(10): 1315-1323.
147. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010; 117(9): 1792-1799.
148. Chen SN, Hwang JF, Tseng LF, Lin CJ. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 2008; 115: 2229-2234.
149. Ricci F, Missiroli F, Regine F, Grossi M, Dorin G. Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 597-607.
150. Gupta B, Elagouz M, McHugh D, Chong V, Sivaprasad S. Micropulse diode laser photocoagulation for central serous chorioretinopathy. Clin Experiment Ophthalmol 2009; 37: 801-805.
151. Lanzetta P, Furlan F, Morgante L, Veritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008; 18(6): 934-940.
152. Cadepond F, Ulmann A, Baulieu EE. RU486 (Mifepristone): Mechanisms of action and clinical uses. AnnuRevMed 1997; 48: 129-156.
153. Caccavale A, Imparato M, Romanazzi F, Negri A, Porta A, Ferentini F. A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses 2009; 73: 435-437.